Non-invasive Aesthetic Treatment Market Size, Share & Trends Analysis Report By Procedure (Skin Rejuvenation, Injectable), By End Use (Hospital/Surgery Center, MedSpa), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Non-invasive Aesthetic Treatment Market Growth & Trends
The global non-invasive aesthetic treatment market size is expected to reach USD 190.5 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 15.2% over the forecast period. Non-invasive aesthetic treatment offers benefits, such as less pain, instant results, and low cost over invasive treatment. Non-invasive aesthetic treatment does not serve permanent results; however, it temporarily enhances facial appearance and aids in delaying the signs of aging. According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), between 2017 and 2018, there was an 11.7% increase in the popularity of nonsurgical procedures and a decrease of 0.6% in surgical procedures. This highlights the high growth prospects that lie ahead for the market in the coming years.
The COVID-19 pandemic has significantly affected the market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected. Practitioners have also raised concerns over the downturn in patient interest owing to a sharp cut in income. The market is expected to witness a phase of short-term negative growth. However, growing initiatives from several manufacturers to mitigate the negative impact of the pandemic have supported the growth in 2021. Inorganic growth strategies, such as new product launches, regional expansion of major players, acquisitions, and mergers, are a few of the initiatives adopted by the key companies that have led to improved revenues between 2020 and 2021. Non-invasive aesthetic treatment includes procedures, such as skin rejuvenation and injectables.
Popular injectable procedures include botulinum toxin, hyaluronic acid, and polymer filler. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin was among the top 5 minimally invasive procedures carried out in the U.S. To avoid aggressive surgical procedures in the future, patients are seen opting for non-surgical treatments to start early in their lives. The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries, such as India and China, which have a huge target population. In Thailand, which is also projected to be the fastest-growing country in the region, the aging population is a growing segment, which will support the market growth.
Non-invasive Aesthetic Treatment Market Report Highlights
Non-invasive Aesthetic Treatment Market Growth & Trends
The global non-invasive aesthetic treatment market size is expected to reach USD 190.5 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 15.2% over the forecast period. Non-invasive aesthetic treatment offers benefits, such as less pain, instant results, and low cost over invasive treatment. Non-invasive aesthetic treatment does not serve permanent results; however, it temporarily enhances facial appearance and aids in delaying the signs of aging. According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), between 2017 and 2018, there was an 11.7% increase in the popularity of nonsurgical procedures and a decrease of 0.6% in surgical procedures. This highlights the high growth prospects that lie ahead for the market in the coming years.
The COVID-19 pandemic has significantly affected the market. The cosmetics industry relies on close physical contact with their clients, leaving it negatively affected. Practitioners have also raised concerns over the downturn in patient interest owing to a sharp cut in income. The market is expected to witness a phase of short-term negative growth. However, growing initiatives from several manufacturers to mitigate the negative impact of the pandemic have supported the growth in 2021. Inorganic growth strategies, such as new product launches, regional expansion of major players, acquisitions, and mergers, are a few of the initiatives adopted by the key companies that have led to improved revenues between 2020 and 2021. Non-invasive aesthetic treatment includes procedures, such as skin rejuvenation and injectables.
Popular injectable procedures include botulinum toxin, hyaluronic acid, and polymer filler. According to the American Society of Plastic Surgeons (ASPS), in 2019, botulinum toxin was among the top 5 minimally invasive procedures carried out in the U.S. To avoid aggressive surgical procedures in the future, patients are seen opting for non-surgical treatments to start early in their lives. The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries, such as India and China, which have a huge target population. In Thailand, which is also projected to be the fastest-growing country in the region, the aging population is a growing segment, which will support the market growth.
Non-invasive Aesthetic Treatment Market Report Highlights
- The injectable procedure segment is projected to dominate the global market throughout the forecast period
- Botulinum toxin is one of the most popular minimally invasive procedures. It is estimated to be the fastest-growing sub-segment during the forecasted period
- This procedure is widely used by working individuals to delay the signs of aging and enhance physical appearance
- North America dominated the market in 2020 due to the availability and adoption of advanced treatment options in this region
- Asia Pacific is projected to witness the fastest CAGR over the forecast period. Young adults in this region are increasingly focusing on physical appearance, which supports market growth
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. NON-INVASIVE AESTHETIC TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Penetration & Growth Prospect Mapping
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing beauty consciousness among consumers
3.2.1.2. Growing geriatric population
3.2.2. Market Restraint Analysis
3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat from new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Social Landscape
3.3.2.3. Technology Landscape
3.3.2.4. Legal Landscape
CHAPTER 4. NON-INVASIVE AESTHETIC TREATMENT MARKET: SEGMENT ANALYSIS, BY PROCEDURE, 2017-2030 (USD MILLION)
4.1. Definitions & Scope
4.2. Procedure market share analysis, 2021 & 2030
4.3. Global Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030
4.4. Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the following
4.4.1. Injectables
4.4.2. Skin Rejuvenation
4.4.3. Others
CHAPTER 5. NON-INVASIVE AESTHETIC TREATMENT MARKET: SEGMENT ANALYSIS, BY END USE, 2017-2030 (USD MILLION)
5.1. Definitions & Scope
5.2. End Use market share analysis, 2021 & 2030
5.3. Global Non-invasive Aesthetic Treatment Market, By End Use, 2017 - 2030
5.4. Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the following
5.4.1. Hospital/Surgery Center
5.4.2. Medspa
5.4.3. Traditional Spa
5.4.4. HCP owned clinic
CHAPTER 6. NON-INVASIVE AESTHETIC TREATMENT MARKET: REGIONAL MARKET ANALYSIS, BY REGION, 2017 - 2030 (USD MILLION)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2021 & 2030
6.3. Regional Market Dashboard
6.4. Market Size, & Forecasts, and Trend Analysis, 2021 to 2030:
6.5. North America
6.5.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.5.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.5.3. U.S.
6.5.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.5.4. Canada
6.5.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6. Europe
6.6.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.6.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.4. U.K.
6.6.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.5. France
6.6.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.6. Italy
6.6.6.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.7. Spain
6.6.7.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.7.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.3. China
6.7.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.4. Japan
6.7.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.5. India
6.7.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.7. South Korea
6.7.7.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8. Latin America
6.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.8.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.3. Brazil
6.8.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.4. Mexico
6.8.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.5. Argentina
6.8.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.6. Colombia
6.8.6.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9. Middle East and Africa
6.9.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.9.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9.3. South Africa
6.9.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9.4. Saudi Arabia
6.9.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9.5. UAE
6.9.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
CHAPTER 7. NON-INVASIVE AESTHETIC TREATMENT MARKET - COMPETITIVE ANALYSIS
7.1. Key companies profiled
7.1.1. Hologic, Inc.
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Allergan, Inc.
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Galderma S.A.
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Alma Lasers
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Syneron Candela
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Johnson & Johnson
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Merz Pharma
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Lumenis
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Solta Medical
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Cutera Inc
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. Product benchmarking
7.1.10.4. Strategic initiatives.
7.1.11. Revance Therapeutics Inc.
7.1.11.1. Company overview
7.1.11.2. Financial performance
7.1.11.3. Product benchmarking
7.1.11.4. Strategic initiatives.
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. NON-INVASIVE AESTHETIC TREATMENT MARKET VARIABLES, TRENDS & SCOPE
3.1. Penetration & Growth Prospect Mapping
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing beauty consciousness among consumers
3.2.1.2. Growing geriatric population
3.2.2. Market Restraint Analysis
3.3. Non-invasive Aesthetic Treatment: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat from new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Social Landscape
3.3.2.3. Technology Landscape
3.3.2.4. Legal Landscape
CHAPTER 4. NON-INVASIVE AESTHETIC TREATMENT MARKET: SEGMENT ANALYSIS, BY PROCEDURE, 2017-2030 (USD MILLION)
4.1. Definitions & Scope
4.2. Procedure market share analysis, 2021 & 2030
4.3. Global Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030
4.4. Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the following
4.4.1. Injectables
4.4.2. Skin Rejuvenation
4.4.3. Others
CHAPTER 5. NON-INVASIVE AESTHETIC TREATMENT MARKET: SEGMENT ANALYSIS, BY END USE, 2017-2030 (USD MILLION)
5.1. Definitions & Scope
5.2. End Use market share analysis, 2021 & 2030
5.3. Global Non-invasive Aesthetic Treatment Market, By End Use, 2017 - 2030
5.4. Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the following
5.4.1. Hospital/Surgery Center
5.4.2. Medspa
5.4.3. Traditional Spa
5.4.4. HCP owned clinic
CHAPTER 6. NON-INVASIVE AESTHETIC TREATMENT MARKET: REGIONAL MARKET ANALYSIS, BY REGION, 2017 - 2030 (USD MILLION)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2021 & 2030
6.3. Regional Market Dashboard
6.4. Market Size, & Forecasts, and Trend Analysis, 2021 to 2030:
6.5. North America
6.5.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.5.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.5.3. U.S.
6.5.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.5.4. Canada
6.5.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6. Europe
6.6.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.6.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.4. U.K.
6.6.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.5. France
6.6.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.6. Italy
6.6.6.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.6.7. Spain
6.6.7.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.7.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.3. China
6.7.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.4. Japan
6.7.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.5. India
6.7.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.7.7. South Korea
6.7.7.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8. Latin America
6.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.8.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.3. Brazil
6.8.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.4. Mexico
6.8.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.5. Argentina
6.8.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.8.6. Colombia
6.8.6.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9. Middle East and Africa
6.9.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.9.2. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9.3. South Africa
6.9.3.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9.4. Saudi Arabia
6.9.4.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
6.9.5. UAE
6.9.5.1. Market estimates and forecast, by procedure, 2017 - 2030 (USD Million)
CHAPTER 7. NON-INVASIVE AESTHETIC TREATMENT MARKET - COMPETITIVE ANALYSIS
7.1. Key companies profiled
7.1.1. Hologic, Inc.
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Allergan, Inc.
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Galderma S.A.
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Alma Lasers
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Syneron Candela
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Johnson & Johnson
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Merz Pharma
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Lumenis
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. Solta Medical
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Cutera Inc
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. Product benchmarking
7.1.10.4. Strategic initiatives.
7.1.11. Revance Therapeutics Inc.
7.1.11.1. Company overview
7.1.11.2. Financial performance
7.1.11.3. Product benchmarking
7.1.11.4. Strategic initiatives.
LIST OF TABLES
Table 1 Global Non-invasive Aesthetic Treatment Market, By Region, 2017 - 2030 (USD Million)
Table 2 Global Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 3 North America Non-invasive Aesthetic Treatment Market, By Country, 2017 - 2030 (USD Million)
Table 4 North America Non-invasive Aesthetic Treatment Market, By Procedure2017 - 2030 (USD Million)
Table 5 U.S. Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 6 Canada Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 7 Europe Non-invasive Aesthetic Treatment Market, By Country, 2017 - 2030 (USD Million)
Table 8 Europe Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 9 U.K. Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 10 Germany Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 11 France Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 12 Italy Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 13 Asia Pacific Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 14 Japan Non-invasive Aesthetic Treatment Market, By Procedure2017 - 2030 (USD Million)
Table 15 China Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 16 India Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 17 Thailand Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 18 South Korea Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 19 Latin America Non-invasive Aesthetic Treatment Market, By Country, 2017 - 2030 (USD Million)
Table 20 Latin America Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 21 Brazil Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 22 Mexico Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 23 Argentina Non-invasive Aesthetic Treatment Market, By Procedure,2017 - 2030 (USD Million)
Table 24 Colombia Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 25 Middle East & Africa Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 26 South Africa Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 27 Saudi Arabia Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 28 UAE Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 1 Global Non-invasive Aesthetic Treatment Market, By Region, 2017 - 2030 (USD Million)
Table 2 Global Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 3 North America Non-invasive Aesthetic Treatment Market, By Country, 2017 - 2030 (USD Million)
Table 4 North America Non-invasive Aesthetic Treatment Market, By Procedure2017 - 2030 (USD Million)
Table 5 U.S. Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 6 Canada Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 7 Europe Non-invasive Aesthetic Treatment Market, By Country, 2017 - 2030 (USD Million)
Table 8 Europe Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 9 U.K. Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 10 Germany Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 11 France Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 12 Italy Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 13 Asia Pacific Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 14 Japan Non-invasive Aesthetic Treatment Market, By Procedure2017 - 2030 (USD Million)
Table 15 China Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 16 India Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 17 Thailand Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 18 South Korea Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 19 Latin America Non-invasive Aesthetic Treatment Market, By Country, 2017 - 2030 (USD Million)
Table 20 Latin America Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 21 Brazil Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 22 Mexico Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 23 Argentina Non-invasive Aesthetic Treatment Market, By Procedure,2017 - 2030 (USD Million)
Table 24 Colombia Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 25 Middle East & Africa Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 26 South Africa Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 27 Saudi Arabia Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
Table 28 UAE Non-invasive Aesthetic Treatment Market, By Procedure, 2017 - 2030 (USD Million)
LIST OF FIGURES
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Non-invasive aesthetic treatment market segmentation
Figure 8 Market driver relevance analysis (Current & future impact)
Figure 9 Market restraint relevance analysis (Current & future impact)
Figure 10 Market challenge relevance analysis (Current & future impact)
Figure 11 Penetration & growth prospect mapping
Figure 12 SWOT analysis, by factor (political & legal, economic and technological)
Figure 13 Porter’s five forces analysis
Figure 14 Market penetration vs growth prospect mapping
Figure 15 Non-invasive aesthetic treatment market: procedure movement analysis
Figure 16 Regional marketplace: Key takeaways
Figure 17 Regional outlook, 2021 & 2030
Figure 18 North America Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 19 U.S. Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 20 Canada Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million))
Figure 21 Europe Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 22 U.K. Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 23 Germany Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 24 Italy Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 25 Spain Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 26 France Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 27 Asia Pacific Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 28 Japan Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 29 China Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 30 India Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 31 Thailand Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 32 South Korea Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 33 Latin America Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 34 Brazil Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 25 Mexico Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 36 Argentina Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 37 Colombia Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 38 MEA Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 39 South Africa Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 40 Saudi Arabia Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 41 UAE Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain-based sizing & forecasting
Figure 6 Market formulation & validation
Figure 7 Non-invasive aesthetic treatment market segmentation
Figure 8 Market driver relevance analysis (Current & future impact)
Figure 9 Market restraint relevance analysis (Current & future impact)
Figure 10 Market challenge relevance analysis (Current & future impact)
Figure 11 Penetration & growth prospect mapping
Figure 12 SWOT analysis, by factor (political & legal, economic and technological)
Figure 13 Porter’s five forces analysis
Figure 14 Market penetration vs growth prospect mapping
Figure 15 Non-invasive aesthetic treatment market: procedure movement analysis
Figure 16 Regional marketplace: Key takeaways
Figure 17 Regional outlook, 2021 & 2030
Figure 18 North America Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 19 U.S. Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 20 Canada Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million))
Figure 21 Europe Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 22 U.K. Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 23 Germany Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 24 Italy Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 25 Spain Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 26 France Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 27 Asia Pacific Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 28 Japan Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 29 China Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 30 India Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 31 Thailand Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 32 South Korea Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 33 Latin America Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 34 Brazil Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 25 Mexico Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 36 Argentina Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 37 Colombia Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 38 MEA Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 39 South Africa Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 40 Saudi Arabia Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
Figure 41 UAE Non-invasive aesthetic treatment market, 2017 - 2030 (USD Million)
